Loading...
Respiratory Syncytial Virus Infection in High-risk Infants – an Update on Palivizumab Prophylaxis
Morbidity due to respiratory syncytial virus (RSV) disease is still high in infants and children worldwide during the first two to five years of life. Certain categories of high-risk infants with increased morbidity and mortality attributed to RSV disease have been identified and are included in nat...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Bentham Open
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4133922/ https://ncbi.nlm.nih.gov/pubmed/25132870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874285801408010071 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|